Literature DB >> 21672921

A natural antisense transcript at the Huntington's disease repeat locus regulates HTT expression.

Daniel W Chung1, Dobrila D Rudnicki, Lan Yu, Russell L Margolis.   

Abstract

Huntington's disease (HD) is a progressive neurodegenerative disorder caused by a CAG repeat expansion in exon 1 of huntingtin (HTT). Relatively little attention has been directed to the genomic features of the antisense strand at the HD locus, though the presence of a transcript from this strand has been suggested by a survey of the entire transcriptome and the existence of several EST tags. In this study, we identified huntingtin antisense (HTTAS), a natural antisense transcript at the HD repeat locus that contain the repeat tract. HTTAS is 5' capped, poly (A) tailed and contains three exons, alternatively spliced into HTTAS_v1 (exons 1 and 3) and HTTAS_v2 (exons 2 and 3). Exon 1 includes the repeat. HTTAS_v1 has a weak promoter, and is expressed at low levels in multiple tissue types and throughout the brain. Reporter assays indicate that while efficient promoter activity requires a short repeat, repeat expansion reduces promoter efficiency. Consistent with the reporter assays, levels of HTTAS_v1 are reduced in human HD frontal cortex. In cell systems, overexpression of HTTAS_v1 specifically reduces endogenous HTT transcript levels, while siRNA knockdown of HTTAS_v1 increases HTT transcript levels. Minigene constructs of the HD locus confirm the regulatory effect of HTTAS_v1 on HTT, and demonstrate that the effect is dependent on repeat length and is at least partially Dicer dependent. Together, these findings provide strong evidence for the existence of a gene antisense to HTT, with properties that include regulation of HTT expression.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21672921      PMCID: PMC3153309          DOI: 10.1093/hmg/ddr263

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  59 in total

1.  An upstream open reading frame impedes translation of the huntingtin gene.

Authors:  Joseph Lee; Eun Hee Park; Graeme Couture; Isabelle Harvey; Philippe Garneau; Jerry Pelletier
Journal:  Nucleic Acids Res       Date:  2002-12-01       Impact factor: 16.971

2.  Reduced androgen receptor gene expression with first exon CAG repeat expansion.

Authors:  C S Choong; J A Kemppainen; Z X Zhou; E M Wilson
Journal:  Mol Endocrinol       Date:  1996-12

3.  A repeat expansion in the gene encoding junctophilin-3 is associated with Huntington disease-like 2.

Authors:  S E Holmes; E O'Hearn; A Rosenblatt; C Callahan; H S Hwang; R G Ingersoll-Ashworth; A Fleisher; G Stevanin; A Brice; N T Potter; C A Ross; R L Margolis
Journal:  Nat Genet       Date:  2001-12       Impact factor: 38.330

4.  Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3' end of a transcript encoding a protein kinase family member.

Authors:  J D Brook; M E McCurrach; H G Harley; A J Buckler; D Church; H Aburatani; K Hunter; V P Stanton; J P Thirion; T Hudson
Journal:  Cell       Date:  1992-04-17       Impact factor: 41.582

5.  Dodecamer repeat expansion in cystatin B gene in progressive myoclonus epilepsy.

Authors:  M D Lalioti; H S Scott; C Buresi; C Rossier; A Bottani; M A Morris; A Malafosse; S E Antonarakis
Journal:  Nature       Date:  1997-04-24       Impact factor: 49.962

6.  Neuronal loss in layers V and VI of cerebral cortex in Huntington's disease.

Authors:  J C Hedreen; C E Peyser; S E Folstein; C A Ross
Journal:  Neurosci Lett       Date:  1991-12-09       Impact factor: 3.046

Review 7.  Protein aggregation and neurodegenerative disease.

Authors:  Christopher A Ross; Michelle A Poirier
Journal:  Nat Med       Date:  2004-07       Impact factor: 53.440

8.  Expression of the mutant allele of IT-15 (the HD gene) in striatum and cortex of Huntington's disease patients.

Authors:  O C Stine; S H Li; N Pleasant; M V Wagster; J C Hedreen; C A Ross
Journal:  Hum Mol Genet       Date:  1995-01       Impact factor: 6.150

9.  Neuropathological classification of Huntington's disease.

Authors:  J P Vonsattel; R H Myers; T J Stevens; R J Ferrante; E D Bird; E P Richardson
Journal:  J Neuropathol Exp Neurol       Date:  1985-11       Impact factor: 3.685

10.  DNA methylation represses FMR-1 transcription in fragile X syndrome.

Authors:  J S Sutcliffe; D L Nelson; F Zhang; M Pieretti; C T Caskey; D Saxe; S T Warren
Journal:  Hum Mol Genet       Date:  1992-09       Impact factor: 6.150

View more
  93 in total

Review 1.  Long non-coding RNAs in corticogenesis: deciphering the non-coding code of the brain.

Authors:  Julieta Aprea; Federico Calegari
Journal:  EMBO J       Date:  2015-10-29       Impact factor: 11.598

Review 2.  Mechanisms of toxicity in C9FTLD/ALS.

Authors:  Tania F Gendron; Veronique V Belzil; Yong-Jie Zhang; Leonard Petrucelli
Journal:  Acta Neuropathol       Date:  2014-01-07       Impact factor: 17.088

Review 3.  Targeting long non-coding RNA to therapeutically upregulate gene expression.

Authors:  Claes Wahlestedt
Journal:  Nat Rev Drug Discov       Date:  2013-06       Impact factor: 84.694

Review 4.  Interplay of chromatin modifications and non-coding RNAs in the heart.

Authors:  Prabhu Mathiyalagan; Samuel T Keating; Xiao-Jun Du; Assam El-Osta
Journal:  Epigenetics       Date:  2013-10-10       Impact factor: 4.528

5.  Targeted degradation of sense and antisense C9orf72 RNA foci as therapy for ALS and frontotemporal degeneration.

Authors:  Clotilde Lagier-Tourenne; Michael Baughn; Frank Rigo; Shuying Sun; Patrick Liu; Hai-Ri Li; Jie Jiang; Andrew T Watt; Seung Chun; Melanie Katz; Jinsong Qiu; Ying Sun; Shuo-Chien Ling; Qiang Zhu; Magdalini Polymenidou; Kevin Drenner; Jonathan W Artates; Melissa McAlonis-Downes; Sebastian Markmiller; Kasey R Hutt; Donald P Pizzo; Janet Cady; Matthew B Harms; Robert H Baloh; Scott R Vandenberg; Gene W Yeo; Xiang-Dong Fu; C Frank Bennett; Don W Cleveland; John Ravits
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-29       Impact factor: 11.205

Review 6.  Invited Review: Long non-coding RNAs: important regulators in the development, function and disorders of the central nervous system.

Authors:  R Cuevas-Diaz Duran; H Wei; D H Kim; J Q Wu
Journal:  Neuropathol Appl Neurobiol       Date:  2019-03-04       Impact factor: 8.090

Review 7.  Models and mechanisms of repeat expansion disorders: a worm's eye view.

Authors:  Paige Rudich; Todd Lamitina
Journal:  J Genet       Date:  2018-07       Impact factor: 1.166

8.  Age-Related Expression of a Repeat-Rich Intergenic Long Noncoding RNA in the Rat Brain.

Authors:  Sukhleen Kour; Pramod C Rath
Journal:  Mol Neurobiol       Date:  2016-01-11       Impact factor: 5.590

9.  Distinct roles for Toll and autophagy pathways in double-stranded RNA toxicity in a Drosophila model of expanded repeat neurodegenerative diseases.

Authors:  Saumya E Samaraweera; Louise V O'Keefe; Gareth R Price; Deon J Venter; Robert I Richards
Journal:  Hum Mol Genet       Date:  2013-03-21       Impact factor: 6.150

Review 10.  Noncoding RNAs in neurodegeneration.

Authors:  Evgenia Salta; Bart De Strooper
Journal:  Nat Rev Neurosci       Date:  2017-08-17       Impact factor: 34.870

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.